146 related articles for article (PubMed ID: 35171885)
21. [Clinicopathological features of Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly].
Xu FP; Liu YH; Zhuang HG; Luo DL; Li L; Zhang F; Luo XL; Du X; Li WY; Chen Q
Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):616-21. PubMed ID: 22177246
[TBL] [Abstract][Full Text] [Related]
22. Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma.
Xie X; Sundram U; Natkunam Y; Kohler S; Hoppe RT; Kim YH; Cook JR; Hammel J; Swerdlow SH; Guitart J; Smith MD; Bosler D; Listinsky C; Lossos IS; Hsi ED
Mod Pathol; 2008 Jun; 21(6):653-9. PubMed ID: 18264083
[TBL] [Abstract][Full Text] [Related]
23. Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphoma.
Pham-Ledard A; Prochazkova-Carlotti M; Andrique L; Cappellen D; Vergier B; Martinez F; Grange F; Petrella T; Beylot-Barry M; Merlio JP
Mod Pathol; 2014 Mar; 27(3):402-11. PubMed ID: 24030746
[TBL] [Abstract][Full Text] [Related]
24. [Clinicopathologic features and expression of OCT4 protein in testicular diffuse large B cell lymphoma].
Chen YP; Zhu WF; Chen LF; Lu JP; He TM; Fu WD; Xu CW; Chen G
Zhonghua Bing Li Xue Za Zhi; 2017 Jun; 46(6):383-387. PubMed ID: 28591984
[No Abstract] [Full Text] [Related]
25. Secondary skin involvement by systemic de novo CD5-positive diffuse large B-cell lymphoma.
Baba N; Fujii K; Ibusuki A; Higashi Y; Kawai K; Kanekura T
J Dermatol; 2018 Jan; 45(1):e15-e16. PubMed ID: 29044655
[No Abstract] [Full Text] [Related]
26. Coexpression of CD5 and CD43 predicts worse prognosis in diffuse large B-cell lymphoma.
Ma XB; Zhong YP; Zheng Y; Jiang J; Wang YP
Cancer Med; 2018 Sep; 7(9):4284-4295. PubMed ID: 30019388
[TBL] [Abstract][Full Text] [Related]
27. [Clinicopathological features of primary cardiac CD5-positive and bcl-2 and C-MYC double expression diffuse large B-cell lymphoma].
Zhang F; Luo DL; Chen Y; Liu J; Luo LQ; He J; Yan JH; Xu J; Luo XL; Liu YH
Zhonghua Bing Li Xue Za Zhi; 2019 Dec; 48(12):951-954. PubMed ID: 31818069
[No Abstract] [Full Text] [Related]
28. Primary and secondary cutaneous diffuse large B-cell lymphomas: a multiparameter analysis of 25 cases including fluorescence in situ hybridization for t(14;18) translocation.
Kim BK; Surti U; Pandya AG; Swerdlow SH
Am J Surg Pathol; 2003 Mar; 27(3):356-64. PubMed ID: 12604892
[TBL] [Abstract][Full Text] [Related]
29. Primary hepatosplenic CD5-positive diffuse large B-cell lymphoma: a case report with literature review.
Zhang X; Sun M; Zhang L; Shao H
Int J Clin Exp Pathol; 2013; 6(5):985-9. PubMed ID: 23638236
[TBL] [Abstract][Full Text] [Related]
30. De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients.
Yamaguchi M; Seto M; Okamoto M; Ichinohasama R; Nakamura N; Yoshino T; Suzumiya J; Murase T; Miura I; Akasaka T; Tamaru J; Suzuki R; Kagami Y; Hirano M; Morishima Y; Ueda R; Shiku H; Nakamura S
Blood; 2002 Feb; 99(3):815-21. PubMed ID: 11806981
[TBL] [Abstract][Full Text] [Related]
31. Lenalidomide combined with R-GDP in a patient with refractory CD5-positive diffuse large B-cell lymphoma: A promising response and review.
Zhang Y; Wang X; Liu Y; Sun C; Shi W; Huang H
Cancer Biol Ther; 2018 Jul; 19(7):549-553. PubMed ID: 29611764
[TBL] [Abstract][Full Text] [Related]
32. Microarray reveals differences in both tumors and vascular specific gene expression in de novo CD5+ and CD5- diffuse large B-cell lymphomas.
Kobayashi T; Yamaguchi M; Kim S; Morikawa J; Ogawa S; Ueno S; Suh E; Dougherty E; Shmulevich I; Shiku H; Zhang W
Cancer Res; 2003 Jan; 63(1):60-6. PubMed ID: 12517778
[TBL] [Abstract][Full Text] [Related]
33. [Primary cutaneous diffuse large B-cell lymphoma, leg type: a study of clinicopathology, immunophenotype and gene rearrangement].
Wang T; Jia L; Liao W; Chen L; Chen X; Xiong Y; Hao F; Zhu X; Yang X; Wang L
Zhonghua Bing Li Xue Za Zhi; 2015 Feb; 44(2):100-5. PubMed ID: 25916640
[TBL] [Abstract][Full Text] [Related]
34. Follicular origin of a subset of CD5+ diffuse large B-cell lymphomas.
Manazza AD; Bonello L; Pagano M; Chiusa L; Novero D; Stacchini A; Martini G; Vitolo U; Tarella C; Inghirami G; Palestro G; Chiarle R
Am J Clin Pathol; 2005 Aug; 124(2):182-90. PubMed ID: 16040287
[TBL] [Abstract][Full Text] [Related]
35. MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.
Takeuchi T; Yamaguchi M; Kobayashi K; Miyazaki K; Tawara I; Imai H; Ono R; Nosaka T; Tanaka K; Katayama N
Cancer; 2017 Apr; 123(7):1166-1173. PubMed ID: 27915469
[TBL] [Abstract][Full Text] [Related]
36. De novo CD5-positive diffuse large B-cell lymphomas show high specificity for cyclin D2 expression.
Igawa T; Sato Y; Takata K; Iwaki N; Tanaka T; Asano N; Maeda Y; Orita Y; Nakamura N; Nakamura S; Yoshino T
Diagn Pathol; 2013 May; 8():81. PubMed ID: 23675804
[TBL] [Abstract][Full Text] [Related]
37. [Marfan syndrome complicated with CD5+ CD10+ diffuse large B-cell lymphoma].
Yoshitake K; Hagiwara Y; Tanae K; Takahashi N; Kohri M; Tamaru J; Bessho M; Niitsu N
Rinsho Ketsueki; 2010 Mar; 51(3):196-200. PubMed ID: 20379114
[TBL] [Abstract][Full Text] [Related]
38. Primary cutaneous diffuse large B-cell lymphoma, leg type and secondary cutaneous involvement by testicular B-cell lymphoma share identical clinicopathological and immunophenotypical features.
Muniesa C; Pujol RM; Estrach MT; Gallardo F; García-Muret MP; Climent J; Salar A; Servitje O
J Am Acad Dermatol; 2012 Apr; 66(4):650-4. PubMed ID: 21816504
[TBL] [Abstract][Full Text] [Related]
39. CD5+ diffuse large B-cell lymphoma has heterogeneous clinical features and poor prognosis: a single-center retrospective study in China.
Yin T; Qi L; Zhou Y; Kong F; Wang S; Yu M; Li F
J Int Med Res; 2022 Sep; 50(9):3000605221110075. PubMed ID: 36112929
[TBL] [Abstract][Full Text] [Related]
40. Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg Type.
Zhou XA; Louissaint A; Wenzel A; Yang J; Martinez-Escala ME; Moy AP; Morgan EA; Paxton CN; Hong B; Andersen EF; Guitart J; Behdad A; Cerroni L; Weinstock DM; Choi J
J Invest Dermatol; 2018 Nov; 138(11):2365-2376. PubMed ID: 29857068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
